Increase in nitric oxide and reductions in blood pressure, protein kinase C β II and oxidative stress by L-carnitine: A study in the fructose-fed hypertensive rat

Clinical and Experimental Hypertension

Volumn 29, Issue 8, 2007, Pages 517-530

  Rajasekar, P ^a   Palanisamy, N ^a   Anuradha, C V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Blood pressure; Free fatty acid; Fructose; L carnitine; PKC II

Indexed keywords

CARNITINE; FATTY ACID; INSULIN; KALLIKREIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN KINASE C BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; HEART MUSCLE; HYPERTENSION; IMMUNOBLOTTING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD PRESSURE; CARNITINE; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; METABOLIC SYNDROME X; NITRIC OXIDE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; PROTEIN KINASE C; RATS; RATS, WISTAR; VITAMIN B COMPLEX;

EID: 36849055496     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701743998     Document Type: Article

References (45)

1. Reaven GM. Syndrome X: Six years later. J Int Med. 1994;736:13-22.
2. Fields M, Lewis CG, Lure M, Antholine WE. The influence of gender on developing copper deficiency and on free radical generation of rats fed a fructose diet. Metabol. 1992;41:989-994.
3. Bulow J, Madsen, Hojgaard L. Reversibility of the effect on local circulation of high lipid concentrations in blood. Scand J Clin Lab Invest. 1990;50:291-296.
4. Donnelly R, Reed MJ, Azhar S, Reaven GM. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructoseinduced insulin resistance. Endocrinology. 1994;135:2369-2374.
5. Cruzado M, Risler N, Castro C, Ortiz A, Ruttler ME. Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels. Am J Hypertens. 1998;11:54-58.
6. Anitha Nandhini AT, Thirunavukkarasu V, Anuradha CV. Potential role of kinins in the effects of taurine in high-fructose-fed rats. Can J Physiol Pharmacol. 2004; 82:1-8.
7. Reaven GM, Ho H, Hoffman BB. Somatostatin inhibits fructose-induced hypertension. Hypertens. 1989;14:117-120.
8. Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic hypertensive rats. J Pharmacol Exp Ther. 1994;271:1334-1337.
9. Bhanot S, McNeill JH, Bryer-Ash M. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertens. 1994;23:308-312.
10. Rajasekar P, Kaviarasan S, Anuradha CV. L-carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetol Croat. 2005;34:21-28.
11. Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci. 2006;78:803-811.
12. Balakrishnan SD, Anuradha CV. Effect of exercise training on blood pressure changes and lipid profile in fructose-fed rats. Med Sci Res. 1997;25:743-748.
13. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta. 1973;46:105-111.
14. Trautschold I, Werle E, Schweitzer G. Kallikrein. In: Bregmeyer HU, ed. Methods in enzymatic analysis, vol. 2. Weinham: Verlag Chemie, Academic Press Inc.; New York, London; 1974:1031-1034.
15. Rock E, Astier C, Lab C, Malpuech C, Nowacki W, Gueux E, Mazur A, Rayssiguier Y. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Mag Res. 1995;8:237-242.
16. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensinconverting enzyme. Anal Biochem. 1979;95:540-548.
17. Pearson DT, Tubbs PK, Chase JFA. Carnitine and acyl carnitine. In: Bergmeyer HU, ed. Methods in enzymatic analysis, vol. 4. Weinham: Verlag Chemie, Academic Press Inc.; New York, London; 1977:1758-1771.
18. Anitha Nandhini AT, Balakrishnan SD, Anuradha CV. Taurine modulates antioxidant potential and controls lipid peroxidation in the aorta of high fructose-fed rats. J Biochem Mol Biol Biophy. 2002;6:129-133.
19. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-478.
20. Dillard CJ, Tappel AL. Fluorescent damage products of lipid peroxidation. Methods Enzymol. 1984;105:337-341.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin's-Phenol reagent. J Biol Chem. 1951;193:265-275.
22. Rauchova H, Dobesova Z, Drahota Z, Zicha J, Kune SJ. The effect of chronic L-carnitine treatment on blood pressure and plasma lipids in spontaneously hypertensive rats. Eur J Pharmacol. 1998;342:235-239.
23. Digiesi V, Cantini F, Bisi G, Guarino G, Brodbeck B. L-carnitine adjuvant therapy in essential hypertension. La Clin Terap. 1994;144:391-395.
24. Suzuki K, Islam KN, Kaneto H, Ookawara T, Taniguchi N. The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase. Electrophoresis. 2000;21:285-288.
25. Reznick AZ, Kagan VE, Ramsey R, Tsuchiya M, Khwaja S, Serbinova JEA, Packer L. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation. Arch Biochem Biophy. 1992;296:394-401.
26. Oparil S, Low J, Koerner TJ. Altered angiotensin I conversion in pulmonary disease. Clin Sci Mol Med Suppl. 1976;51:537-543.
27. Cachofeiro V, Maeso R, Munoz-Garcia R, Lahera V. The potential role of nitric oxide in angiotensin II receptor blockade. Blood Press. 1996;5:29-35.
28. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hyper. 1991;4:260-262.
29. Katori M, Majima M. Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship. Japn J Pharmacol. 1996;70:95-128.
30. Shimamoto K, Ura N, Tanaka S, et al. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases. Jap Circ J. 1981;45:1092-1097.
31. Harvey JN, Jaffa AA, Margolius HS, Mayfield RK. Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes. 1990;39:299-304.
32. Ikemoto F, Song G, Tominaga M, Yamamoto K. Oxidation-induced increase in activity of angiotensin converting enzyme in the rat kidney. Biochem Biophy Res Commun. 1988;153:1032-1037.
33. Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K. Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertens. 2002;40:190-194.
34. Kamata K, Yamashita K. Insulin resistance and impaired endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens. 1999;9:370-376.
35. Oshida Y, Tachi Y, Morishita Y, Kitakoshi K, Fuku N, Han YQ, Ohsawa I, Sato Y. Nitric oxide decreases insulin resistance induced by high-fructose feeding. Hormone Metabol Res. 2000;32:339-342.
36. Cameron NE, Cotter MA. Neurovascular effects of L-carnitine treatment in diabetic rats. Eur J Pharmacol. 1997;319:239-244.
37. Gomez-Amores L, Mate A, Miguel-Carrasco JL, Jimenez L, Jos A, Camean, AM, Revilla E, Santa-Maria C, Vazquez CM. L-Carnitine attenuates oxidative stress in hypertensive rats. J Nutr Biochem 2006; in press
38. Unger RH. Lipotoxic diseases. Ann Rev Med. 2002;53:319-336.
39. Kelly DP, Strauss AW. Inherited cardiomyopathies. New Eng J Med. 1994;330:913-919.
40. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003;14:S227-S232.
41. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab Care. 1991;14:173-194.
42. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res. 2002;90:107-111.
43. Zhang Y, Bloem LJ, Yu L, Estridge TB, Iversen PW, McDonald CE, Schrementi JP, Wang X, Vlahos CJ, Wang J. Protein kinase C?βΠ?activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes. Cardiovas Res. 2003;57:139-146.
44. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metabol Cardiovas Dis. 2000;10:339-346.
45. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem. 2002;238:111-117.